This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego
Register Now
Menu
Book Now

Brian Finan, PhD
Vice President - Obesity Research at Novo Nordisk

Agenda Sessions

  • Discovery and Development of Cagrilintide for the Treatment of Obesity

    , 11:45am
    View Session

Speakers at this event

Prev
Next
George Flores
Technical Solutions Manager
Asahi Kasei Bioprocess America

See Brian Speak

Register Now